Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
Gang Huang(Shanghai Jiao Tong University), Meng-Chao Wu(Second Military Medical University), Feng Shen(University of Pennsylvania), Wan Yee Lau(Chinese University of Hong Kong), Weiping Zhou(Second Military Medical University), Shengxian Yuan(Second Military Medical University), Zhenguang Wang(Beijing Institute of Technology), Ze‐Ya Pan(Second Military Medical University)
Cited by 229
Related Papers
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335
Systemic Cytokine Response After Laparoscopic-Assisted Resection of Rectosigmoid Carcinoma
|Annals of Surgery|2000|254